Skip to content
healthcare.dev

ATORVASTATIN CALCIUM

NDC 70518-0186, ATORVASTATIN CALCIUM, tablet, film coated, from REMEDYREPACK INC..

Product NDC
70518-0186
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090548
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0186 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE20 mg/1

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
70518-0186-07051801860030 TABLET, FILM COATED in 1 BLISTER PACK (70518-0186-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e91c673d-c26c-4ff1-90d2-2b9d47a8d771

Use it

Look up 70518-0186 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0186 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-0186. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.